HOME >> BIOLOGY >> NEWS
ANU medical researcher wins national award

ANU immunologist Professor Chris Goodnow has been awarded the Commonwealth Health Minister's Award for Excellence in Health and Medical Research for his research in molecular genetics.

Professor Goodnow, the Director of the Australian Phenomics Facility and Head of the Medical Genome Centre at the John Curtin School of Medical Research, said the award recognised a forward-looking medical research program underway at ANU based on a 'roadmap' of the human genome.

"I'm thrilled to have received this prestigious award from the Australian Government - it is not only satisfying for me personally, but it also is added confirmation of a bold strategy being undertaken at ANU to discover the mechanisms of immune regulation," Professor Goodnow said.

"The next decade of medical science will be driven by investigation of the genome sequence, and research at the John Curtin School of Medical Research is already focusing on this area."

Professor Goodnow said that the Federal Government-funded Australian Phenomics Facility will be a driving force in this genome research, with its program for screening hundreds of thousands of gene sequences and making them accessible to medical researchers around the world.

It has already led to a number of breakthroughs at ANU in one of the largest health problems in the community - dysfunction of the immune system. Autoimmune diseases include type 1 diabetes, rheumatoid arthritis, systemic lupus and multiple sclerosis.

"The research program is a clear example of how ANU leads Australian and international research by looking over the horizon and starting new research fields in anticipation of future of developments - in this case anticipating the sequence of the human genome.

"This current work lays out a genetic roadmap for developing ways to prevent or cure diabetes and other autoimmune diseases, which collectively affect one in 20 Australians.

"It looks into genes and gene mechanis
'"/>

Contact: Tim Winkler
tim.winkler@anu.edu.au
61-2-6125-5001
Research Australia
10-Jun-2005


Page: 1 2

Related biology news :

1. New proteomics research promises to revolutionize biomedical discovery
2. New medical implants should react with the body, not seek to be inert
3. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences
4. Methodist, University of Houston, Cornell combine biomedical imaging expertise
5. Research center unites biomedical competitors to fund medical technology development
6. FSU researchers reap $1-million grant to make medical implants safer
7. New Arizona alliance aims to boost technologies for medical diagnostics and human health
8. Yale biophysicist Thomas Steitz receives Gairdner Award for medical research
9. DNA sequence of Rhesus macaque has evolutionary, medical implications
10. 4th International Conference on Ethical Issues in Biomedical Engineering
11. UT Metroplex institutions to collaborate on biomedical research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ANU medical researcher wins national award

(Date:10/15/2014)... to bacterial pneumonia in female mice to an enzyme ... are naturally more resistant to respiratory infections than males. ... increased resistance to bacterial pneumonia in female mice is ... They also show that this enzyme is ultimately activated ... , The team, lead by Professor Lester Kobzik at ...
(Date:10/15/2014)... , Oct. 15, 2014   Neurotechnology ... today announced the availability of the VeriLook ... Surveillance 3.0 provides real-time biometric face identification using ... digital surveillance cameras. The new version not only ... differentiates people from objects while they are moving ...
(Date:10/14/2014)... of years since T. rex took its ... scientists is breathing life back into dinosaurs using high-powered ... research has important implications for how dinosaurs used their ... sense of smell and cool their brains. , ... student Jason Bourke, lead author of the new study ...
Breaking Biology News(10 mins):VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
(Date:10/22/2014)... -- Nuvilex, Inc. (OTCQB: NVLX) – According to the ... living with diabetes, with  that number expected to grow ... for diabetes treatments is approximately $500 billion.  ... pancreatic cancer.  Pancreatic cancer is the fourth most common ... the United States , and according to a ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
Cached News: